Concepedia

Dehua Lu

DL

Statistics

Publications

21

Citations

725

H-Index

17

Active since

2017

Affiliations

Peking University(Current)

China Pharmaceutical University

State Key Laboratory of Natural Medicine

Peking University Cancer Hospital

Institute of Biophysics

Dehua Lu is an author at Peking University specializing in medicine, pharmacology, and radiation oncology.

ORCID

Top concepts

Publications per year

2017–2024

21

Publications

21

Noninvasive Imaging of CD206-Positive M2 Macrophages as an Early Biomarker for Post-Chemotherapy Tumor Relapse and Lymph Node Metastasis

Chenran Zhang, Xinhe Yu, Liquan Gao et al. · Theranostics · 2017 · 105 citations · Full text

Discovery of First-in-Class Dual PARP and EZH2 Inhibitors for Triple-Negative Breast Cancer with Wild-Type BRCA

Chéng Wáng, Lailiang Qu, Shang Li et al. · Journal of Medicinal Chemistry · 2021 · 96 citations · Full text

Discovery of precision targeting EZH2 degraders for triple-negative breast cancer

Cheng Wang, Xinye Chen, Xingchen Liu et al. · European Journal of Medicinal Chemistry · 2022 · 54 citations

, , +11

Clinical Translation of a<sup>68</sup>Ga-Labeled Integrin α<sub>v</sub>β<sub>6</sub>–Targeting Cyclic Radiotracer for PET Imaging of Pancreatic Cancer

Xun Feng, Yanpu Wang, Dehua Lu et al. · Journal of Nuclear Medicine · 2020 · 47 citations · Full text

Discovery of PT-65 as a highly potent and selective Proteolysis-targeting chimera degrader of GSK3 for treating Alzheimer's disease

Lailiang Qu, Shang Li, Limei Ji et al. · European Journal of Medicinal Chemistry · 2021 · 45 citations · Full text

, , +7

1–5 of 21